The Preclinical Evaluation of Toxicity of 4-(N)-Docosahexaenoyl 2 ́, 2 ́- Difluorodeoxycytidine, a Compound with Potent Antitumor Activity

2016 ◽  
Author(s):  
Solange Valdes
Keyword(s):  
Antitumor Activity ◽  
Preclinical Evaluation

scholarly journals Preclinical evaluation of M30 and M65 ELISAs as biomarkers of drug induced tumor cell death and antitumor activity

2008 ◽  
Vol 7 (3) ◽  
pp. 455-463 ◽  
Author(s):  
Jeffrey Cummings ◽  
Cassandra Hodgkinson ◽  
Rajesh Odedra ◽  
Patrizia Sini ◽  
Simon P. Heaton ◽  
...  
Keyword(s):  
Cell Death ◽  
Antitumor Activity ◽  
Tumor Cell ◽  
Tumor Cell Death ◽  
Drug Induced ◽  
Preclinical Evaluation

scholarly journals Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor

Oncotarget ◽  
2016 ◽  
Vol 7 (14) ◽  
pp. 18171-18182 ◽  
Author(s):  
Suyoun Chung ◽  
Kyoko Kijima ◽  
Aiko Kudo ◽  
Yoshiko Fujisawa ◽  
Yosuke Harada ◽  
...  
Keyword(s):  
Antitumor Activity ◽  
Preclinical Evaluation

scholarly journals Correction: Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor

Oncotarget ◽  
2020 ◽  
Vol 11 (41) ◽  
pp. 3749-3750
Author(s):  
Suyoun Chung ◽  
Kyoko Kijima ◽  
Aiko Kudo ◽  
Yoshiko Fujisawa ◽  
Yosuke Harada ◽  
...  
Keyword(s):  
Antitumor Activity ◽  
Preclinical Evaluation

scholarly journals Preclinical evaluation of Amblyomin-X, a Kunitz-type protease inhibitor with antitumor activity

2019 ◽  
Vol 6 ◽  
pp. 51-63 ◽  
Author(s):  
Durvanei A. Maria ◽  
Sonia Elisabete A.L. Will ◽  
Rosemary V. Bosch ◽  
Jean G. Souza ◽  
Juliana M. Sciani ◽  
...  
Keyword(s):  
Antitumor Activity ◽  
Protease Inhibitor ◽  
Preclinical Evaluation ◽  
Kunitz Type ◽  
Kunitz Type Protease Inhibitor
Sign in / Sign up

Export Citation Format

Share Document